News & Events

Recent Firm Activities and Highlights

Boston Millennia Parters
Dana Callow to Participate in Richi Entrepreneurial Boston Talks Panel “Corporate Strategic Investors in Life Sciences”
On April 17th Dana Callow will participate in the Richi Entrepreneurs Boston Talks: an inspiring series of free fireside chats for life sciences entrepreneurs featuring VC Partners and leading experts from the world's largest life science ecosystem. Gain Insights on starting, funding, and scaling your startup. Experience a glimpse of Richi Entrepreneurs' sessions and speakers. Join us for captivating conversations hosted by the knowledgeable Samuel M. Shafner. Read Full Release
Boston Millennia Parters
Dana Callow to speak at BioIT World in Boston this April
Dana Callow, Managing General Partner of Boston Millennia Partners, will participate on the Empowering Innovation: Build vs. Buy in Data Science and Engineering during BioIT World this April 17th at the Omni Seaport Boston. Read Full Release
Boston Millennia Parters
BMP Portfolio Company, Reveleer, Secures $65 Million in Financing to Drive Strategic Expansion and Enhance Product Offerings
Reveleer, a leading AI-powered healthcare technology data and analytics company committed to advancing sustainable value-based care for health plans and risk-bearing providers, today announced it has raised over $65 million in new capital in a financing round. "This funding will have a tremendous impact as it positions us to strategically pursue inorganic growth opportunities in value-based-care technology, accelerating innovation and enhancing patient care through healthcare AI technology,” said Jay Ackerman, CEO and President at Reveleer. Read Full Release
Boston Millennia Parters
COTA “Real World Talk” Discusses Bias in Clinical Research
BMP Portfolio Company, COTA, discusses bias in clinical research with experts Laura Fernandes and Sesh Srinivasan in the most recent "Real World Talk". Host, Sandy Leonard, sets the stage by highlighting recent regulatory responses and the growing attention on the topic, emphasizing its significance in the realm of real-world data and evidence. Read Full Release
Boston Millennia Parters
Somalogic Merges with Standard BioTools, Inc.
Boston Millennia Portfolio Company, Somalogic, announced their merger with Standard BioTools, Inc. (Nasdaq: LAB). Standard BioTools has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. The merger will create one company that is a diversified leader in life sciences tools. Read Full Release
Boston Millennia Parters
BMP Congratulates COTA CEO, Miruna Sasu, on being named one of the Top 25 Women in Biotech 2022
Congratulations to Cota CEO, Miruna Sasu who has been named one of the Top 25 CEOs in Biotech 2022 by The Healthcare Technology Report. Miruna is joined on a list of exceptional women in healthcare who are working to improve science and health through innovation. Read Full Release
Boston Millennia Parters
BMP Portfolio Company, COTA, Partners with Google Cloud to Transform Cancer Care
COTA, Inc. , an oncology real-world data and analytics company, announced a new partnership with Google Cloud to develop algorithms that will extract and make sense of unstructured data from electronic health records (EHRs). The companies will apply machine learning and natural language processing to curate text fields like clinician notes, transforming them into structured fields that can be used for research and analytics. Read Full Release
Boston Millennia Parters
SomaLogic presents new research at American Heart Association Scientific Sessions
BMP portfolio company, SomaLogic, (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced findings from key studies demonstrating the broad and deep role proteomics plays in detecting cardiovascular risk, achieving optimal cardiometabolic health, and assessing the correlation of cardiovascular disease with other diseases that are among the leading causes of death around the world. SomaLogic and its research partners will present these studies at American Heart Association Scientific Sessions in Chicago on November 5-7, 2022. Read Full Release